Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2000
12/26/2000CA2170322C Process for preparing sphingomyelin and ceramide from erythrocyte as a starting material and a curing agent or cosmetic formulated with ceramide
12/21/2000WO2000077256A1 48 human secreted proteins
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077173A1 42 human secreted proteins
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000077018A2 Purine derivatives
12/21/2000WO2000076972A1 N-cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076515A1 Il-8 receptor antagonists
12/21/2000WO2000076505A1 Amide substituted imidazoquinolines
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076464A2 Oxidatively stable, long-chain ethyl ester emollients
12/21/2000WO2000076452A2 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000WO2000076437A1 Soluble keratin peptide
12/21/2000WO2000066736B1 Growth factor homolog zvegf4
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000050047A3 Composition for the treatment of psoriasis
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000038660A3 Use of bisphosphonates for the prevention and treatment of infectious processes
12/21/2000DE19925739A1 Therapeutikum mit einem Botulinum-Neurotoxin Agent with a botulinum neurotoxin
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2382185A1 48 human secreted proteins
12/21/2000CA2379048A1 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000CA2377391A1 Il-8 receptor antagonists
12/21/2000CA2377334A1 Compositions and systems for the treatment of hyperpigmentation
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376889A1 Soluble keratin peptide
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/20/2000EP1060732A2 Novel topical formulations comprising vesicle delivery systems
12/20/2000EP1060242A1 Purified populations of stem cells
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060181A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
12/20/2000EP1060175A2 Tryptase inhibitors
12/20/2000EP1060171A2 Tryptase inhibitors
12/20/2000EP1060161A1 Matrix metalloproteinase inhibitors
12/20/2000EP1060011A1 Matrix for preparing microparticles or nanoparticles, method for making said particles and resulting particles
12/20/2000EP1059943A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
12/20/2000EP1059940A2 Method for treating painful conditions of the anal region and compositions therefor
12/20/2000EP1059934A2 Matrix protein compositions for wound healing
12/20/2000EP1059931A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
12/20/2000EP1059928A1 Inorganic nitrite and organic acid in combination as topical antiviral composition
12/20/2000EP1059920A1 Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis
12/20/2000EP1059911A1 Formulations with an anti-viral effect
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0823848A4 Tissue adhesive using synthetic cross-linking
12/20/2000EP0788352B1 Treatment of animals
12/20/2000EP0778733B1 A basic protein composition for killing or inhibiting microbial cells
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277055A Burns treating ointment
12/20/2000CN1277048A Recipe of medicine for acne and plane warts
12/20/2000CN1277036A Ointment to eliminate virulent heat-evil
12/20/2000CN1277031A Psoriasis resisting capsule and its preparation
12/20/2000CN1277016A Ointment for treating sweety feet and body odor and its preparation
12/20/2000CN1059596C 搽剂 Liniment
12/20/2000CN1059589C Chinese herbal medicine for wound
12/20/2000CN1059585C A new type scald ointment
12/20/2000CN1059579C Multiple-effect ointment for treating various surgical diseases
12/20/2000CN1059577C Capsule and ointment for skin diseases
12/20/2000CN1059573C Myogenic liniment for relieving pain
12/20/2000CN1059571C Medicinal capsule for replenishing vital essence and marrow beautifying and antisenility
12/20/2000CN1059558C Bee glue powder and its producing process
12/19/2000US6162830 Antihistamines, antiallergens, bone disorders
12/19/2000US6162808 Compounds
12/19/2000US6162791 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/19/2000US6162790 Oligopeptides
12/19/2000US6162774 Mixture of salicylic acid, maleic acid and pyruvic acid with detergent base
12/19/2000US6162600 Indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/19/2000US6162450 Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
12/19/2000US6162445 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof
12/19/2000US6162444 Cosmetic or pharmaceutical compositions
12/19/2000US6162419 Stabilized ascorbyl compositions
12/19/2000CA2159787C Dibenzofuran aromatic derivatives; pharmaceutical and cosmetic compositions containing the same
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075290A1 Method for multiplying stem cells
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000WO2000075126A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000WO2000075117A1 Compositions and methods for inhibiting cell death
1 ... 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 ... 1065